Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Share this content:

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Sponsors and Collaborators
AIDS Malignancy Clinical Trials Consortium
National Cancer Institute (NCI)

United States, California
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States, 92093-0658 Contact: Clinical Trials Office - Rebecca and John Moores UCSD Cancer     858-822-5354    

UCLA Clinical AIDS Research and Education (CARE) Center Recruiting Los Angeles, California, United States, 90095-1793 Contact: Ronald T. Mitsuyasu, MD     310-557-1893    
United States, Maryland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce     410-955-8804    

United States, Massachusetts
Boston University Cancer Research, Boston, Massachusetts, United States, 02118 Contact: Timothy Cooley, MD     617-638-7520        

United States, Missouri
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States, 63110 Contact: Lee Ratner, MD, PhD     314-362-8836    

United States, New York
Memorial Sloan-Kettering Cancer Center, New York, New York, United States, 10065 Contact: Susan E. Krown, MD     212-639-7426    

United States, Washington

Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington, United States, 98101 Contact: Clinical Trials Office - Benaroya Research Institute     206-583-6526

Principal Investigators
Erin G. Reid, MD
University of California, San Diego Identifier

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs